Knocking down PVT1 significantly reduced tumor volume in bladder, prostate, breast, and lung cancer, as well as hepatocellular carcinoma and glioma (24, 25, 37, 48, 55, 63, 66). The gene discussed is PVT1; the disease is neoplasm.